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Background: Worldwide, acute gastroenteritis causes substantial morbidity and mortality in children less than five
years of age. In Bolivia, which has one of the lower GDPs in South America, 16% of child deaths can be attributed
to diarrhea, and the costs associated with diarrhea can weigh heavily on patient families. To address this need, the
study goal was to identify predictors of cost burden (diarrhea-related costs incurred as a percentage of annual
income) and catastrophic cost (cost burden ≥ 1% of annual household income).
Methods: From 2007 to 2009, researchers interviewed caregivers (n = 1,107) of pediatric patients (<5 years old)
seeking treatment for diarrhea in six Bolivian hospitals. Caregivers were surveyed on demographics, clinical
symptoms, direct (e.g. medication, consult fees), and indirect (e.g. lost wages) costs. Multivariate regression models
(n = 551) were used to assess relationships of covariates to the outcomes of cost burden (linear model) and
catastrophic cost (logistic model).
Results: We determined that cost burden and catastrophic cost shared the same significant (p < 0.05) predictors. In
the logistic model that also controlled for child sex, child age, household size, rural residence, transportations taken
to the current visit, whether the child presented with complications, and whether this was the child’s first episode
of diarrhea, significant predictors of catastrophic cost included outpatient status (OR 0.16, 95% CI [0.07, 0.37]);
seeking care at a private hospital (OR 4.12, 95% CI [2.30, 7.41]); having previously sought treatment for this diarrheal
episode (OR 3.92, 95% CI [1.64, 9.35]); and the number of days the child had diarrhea prior to the current visit (OR
1.14, 95% CI [1.05, 1.24]).
Conclusions: Our analysis highlights the economic impact of pediatric diarrhea from the familial perspective and
provides insight into potential areas of intervention to reduce associated economic burden.
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Worldwide, acute gastroenteritis causes substantial mor-
bidity and mortality in children under five years of age,
with 1.4 billion episodes and 1.7 to 3 million deaths each
year [1]. Diarrhea accounts for 21% of all child deaths in
low and middle income countries (LMIC) [2]. Gastro-
enteritis presents an economic burden to both health-
care systems and patient families [3-5]. Though various
studies have attempted to quantify the costs associated
with pediatric diarrhea from the state perspective [3-12],
fewer studies have specifically examined the perspective
of the patient’s family [8-10,13-16], despite the burden
that these costs may represent. Though health insurance
may cover some costs associated with pediatric diarrhea,
patient families often still incur substantial “direct”
(i.e., out-of-pocket) and “indirect” (i.e., lost income) ex-
penses [16-19]. Studies have estimated average total familial
costs (direct and indirect) per episode of hospitalized
pediatric diarrhea ranging from US$19.86 in Kenya
(2007USD [6]) to US$215.88 in Mexico (2003USD [11]).
Direct costs, alone, for a pediatric diarrhea episode have
ranged from US$12.89 per case in Brazil (2007USD [13])
to US$31.83 per case in Vietnam (2004USD [4]). In a
low-resource setting, these costs can represent a large
proportion of a family’s overall budget. In one study in
India, direct costs incurred per diarrheal episode ranged
2.2 – 5.8% of the household’s annual income [14]. The
ratio of total incurred costs for a single diarrheal episode
as a percentage of annual family income, termed the
“cost burden,” has been infrequently studied. Nonethe-
less, large cost burdens incurred from healthcare ex-
penses can have a serious effect on a family’s overall
current and future economic situation, especially for
families already on the edge of poverty (reviewed in
[20,21]). Healthcare costs that cause poverty (e.g. by for-
cing a family to spend money needed for food or other
basic necessities) are termed “catastrophic” [22]. There is
little consensus in the literature as to the exact calcu-
lations and cut-offs that are most appropriate for defin-
ing catastrophic costs [23,24]. Some advocate the use
of a cut-off based on expenditures as a percentage of
“capacity to pay” (non-subsistence spending) [22,25,26].
However, when detailed information on household
expenditures is not available, the use of a cut-off based
on cost burden may be useful. While a cost burden of
10% of annual income is often used to define “cata-
strophic cost” [24,27], lower limits can also be cata-
strophic for poor households [21,28]. For example, in a
study of catastrophic healthcare costs in Thailand, a cost
burden of 10% of monthly income was utilized, which is
equivalent to approximately 1% of annual income [29].
Bolivia has one of the lower GDPs in South America
(per-capita 2013 GDP US$5,500) [30] and has high rates
of child mortality. As of 2012, for every 1,000 live birthsin Bolivia, 41 children die before age five, with an esti-
mated 8% of these deaths from diarrhea [31]. The
cumulative financial impact of these diarrheal episodes
may be severe in this setting, where 30% of the popula-
tion lives on under US$2 per day (2009 est.) [30].
Although Bolivia does have a health program (Seguro
Universal Materno-Infantil, SUMI) that covers children
under five, families must register to benefit from free
care [32]. In addition, free treatment to registered fam-
ilies may not be enforced (e.g. oversight, intentionally),
benefits are only available at public healthcare settings,
and not all potential treatments are eligible for cover-
age. Further, if medications are out of stock at the treat-
ing facility, caregivers may need to purchase drugs
from pharmacies where SUMI does not apply. Thus,
Bolivian families may still incur substantial costs
related to pediatric diarrhea.
The goal of this study was to characterize the financial
effects and potential predictors of costs due to an epi-
sode of pediatric diarrhea on the caregivers of Bolivian
children (under five) who sought treatment for diarrhea
from 2007 through 2009, prior to full implementation of
the vaccine against rotavirus (a major cause of pediatric
diarrhea [33]) into the immunization schedule [34-36].
Methods
This work was done in collaboration with, but independ-
ently from, the Rotavirus Surveillance Project of Bolivia.
Sample population and recruitment
Caregivers of children suffering from diarrhea were
recruited from 2007 to 2009 in outpatient clinics, hos-
pital wards, and emergency rooms in six healthcare
settings across four cities: Hospital Boliviano Holandés
in El Alto, Hospital Materno-Infantil and Hospital del
Niño in La Paz, Centro de Pediatría Albina R. de Patiño
and Hospital Germán Urquidi in Cochabamba, and
Hospital Mario Ortiz Suárez in Santa Cruz. All six
hospitals were sentinel sites for rotavirus surveillance,
located in the four major cities of Bolivia; all provide
both inpatient and outpatient care, and are located
primarily in urban or peri-urban environments (though
do draw some patients from rural areas). The sample
size of 1,107 was estimated from the World Health
Organization (WHO) report “Guidelines for Estimating
the Economic Burden of Diarrheal disease with focus
on Assessing the Costs of Rotavirus Diarrhea” [17]. To
achieve a 10% precision and 0.5 coefficient of variation
per hospital, at least 49 records were collected from each
hospital. Based on sufficient sample size for analysis and
ability to compare across hospitals and cities, only
inpatient (N = 254) and outpatient (N = 297) visits with
valid income data were considered, while emergency
department (N = 80) and pharmacy (N = 2) were excluded;
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from Hospitals Materno-Infantil and del Niño were also
excluded for this reason (n < 10).
Potentially eligible caregivers were identified by attend-
ing clinicians (inpatients) or by study staff (outpatients).
Clinicians confirmed diagnosis of acute pediatric diarrhea
(non-bloody) as well as any complications (e.g. dehy-
dration) with which children presented. Study staff
explained the study and obtained consent. Caregivers
were eligible if they were at least 18 years old and were
responsible for a child under five who was currently
receiving treatment for acute diarrhea.
Prior to data collection, the study was approved by
Emory University’s Institutional Review Board (Protocol
IRB00004406) and the Bolivian National Bioethics
Committee.
Healthcare cost determination and definitions
Healthcare costs were obtained from caregivers via ques-
tionnaires administered by trained study staff (question-
naire available upon request). Caregivers reported any
costs that they incurred out of pocket. As described
above, caregivers may incur out-of-pocket expenses if
they are not be enrolled in SUMI, or may intentionally
or unintentionally be asked to pay for SUMI-eligible
expenses. The interview guide was informed by the
same WHO report described above [17]. Variables were
defined and calculated as described in Table 1. Costs in
Bolivianos (BOB) were converted into USD using the 2012
exchange rate of 1 BOB equal to US$0.146. Costs wereTable 1 Calculations and definitions of cost variables as used
Bolivian children (n = 551) seeking treatment for acute diarrh
Variable Calculation
Direct Medical Costs1 Sum of fees or costs associated with
previous treatment for this diarrheal
Direct Non-Medical Costs1 Sum of costs of transportation to an
episode), food bought during the ho
extra diapers purchased during the v
the caregiver’s other children during
Total Direct Costs1 Sum of medical and non-medical di
Indirect Costs1 Sum of lost wages by caregiver and
and her spouse, and 2) the number
episode.
Total Incurred Costs1 Sum of Total Direct and Total Indirec
Annual Household Income Sum of reported monthly incomes f
missing and the caregiver reported h
(n = 305). Where spousal salary was m
zero (n = 16). Otherwise, missing sala
household income equaled the valu
salaries, then the household income
Cost Burden2 Total Incurred Costs divided by the A
Catastrophic Cost2 Cost Burden greater than or equal to
suggests that this is an appropriate c
1Based on definitions from the WHO guidelines for assessing the cost burden of dia
2Consistent with definitions by Weraphong et al. [29].rounded to the nearest US$0.50. The diagnosis of an
acute diarrheal episode was confirmed by clinicians,
and its duration was reported by the caregiver via
questionnaire.
Data entry and database management
Trained staff collected all data. Two separate staff double-
entered data using Epi Info (v. 3.4.3). The two databases
were compared, and discrepancies logged and corrected
according to a paper copy of the survey. A random sample
of 5% of the records was checked against the original data
to confirm a 100% match.
Statistical methods
All data cleaning and analyses were completed in SAS
version 9.3 (Cary, NC). We used Spearman correlation
coefficients (continuous variables), chi-square tests (cat-
egorical variables), and parametric (Analysis of Variance
[ANOVA]) and non-parametric (Kruskal Wallis) tests to
assess relationships among cost burden, catastrophic
cost, and potential predictors. Multivariate regression
was used to examine relationships among potential
predictors and log10 of cost burden (linear, transformed to
meet normality assumptions) or catastrophic cost burden
(logistic).
Potential predictors (including interactions) were se-
lected based on a priori and data-driven criteria, as
well as data availability. Collinearity was not present in
linear or logistic models (logistic assessed via Collinearity
Diagnostics Information Matrix macro for SAS [37]).in analyses of cost burden and catastrophic cost for
ea, 2007 – 2009
diagnostics, cost of medication, consultation fees, and any costs of
episode.
d from the appointment (and previous appointments for this diarrheal
spital visit (which caregivers perceived as otherwise unnecessary),
isit (perceived as above a family’s standard supply), and childcare for
the episode.
rect costs.
his or her spouse, based on the caregiver’s report of 1) salary for herself
of days of work missed by herself and her spouse due to this diarrheal
t Costs.
or the caregiver and spouse, multiplied by 12. Where caregiver salary was
aving no job or being a homemaker, caregiver salary was set to zero
issing and the spouse was reported as jobless, spousal salary was set to
ries were left missing. If at least one parent reported a salary, then the
e reported by the salary-generating parent. If both parents had missing
was considered missing data and excluded from analysis.
nnual Household Income and expressed as a percentage.
1% of annual income, approximately 10% of monthly income. Research
ut-off for hardship, in low-income settings.
rrhea [17].
Table 2 Characteristics of the study population (n = 551)
of Bolivian children seeking hospital care for diarrheal
episodes, 2007 - 2009
Characteristic n Frequency (Percent)
or mean (SD)
Demographics
Caregiver relationship to child 542
Mother 493 (91.0)
Father 38 (7.0)
Other relative 11 (2.0)
Male child 550 302 (54.9)
Age of child (months) 524 12.6 (9.5)
Rural residence 458 81 (17.7)
SUMI† 313 266 (85.0)
Hospital (City) 536
Del Niño (La Paz) 25 (4.7)
Materno-Infantil (La Paz) 25 (4.7)
Boliviano Holandés (El Alto) 61 (11.4)
Germán Urquidi (Cochabamba) 75 (14.0)
Albina Patiño (Cochabamba)‡ 203 (37.9)
Mario Ortiz Suárez (Santa Cruz) 147 (27.4)




Dual-income household 477 145 (30.4)
Treatment-Seeking Behavior
Sought treatment at least once
previously to current visit
467 384 (82.2)
Number of transportations taken
to current visit
428 1.3 (0.5)
Number of days child had diarrhea
prior to current visit
513 4.9 (7.4)
Severity of illness
Child was an outpatient 551 297 (53.9)
Child presented with at least one
complication§
548 280 (51.1)
Child’s first episode of diarrhea in
their life
466 164 (35.2)
†Universal insurance program for Bolivian children <5 and pregnant women
(covered up to 6 mo. post partum). ‡Private hospital. §Complications defined
as at least one of the following, as diagnosed by the attending physician:
electrolyte disorder, electrolyte imbalance, hypokalemia, metabolic acidosis,
anemia, malnutrition, acute respiratory infection, bronchopneumonia,
intussusception, dehydration, or any other unnamed complication.
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backwards elimination of potential interaction terms
and required all models to be hierarchically well formu-
lated [38]. Potential interactions in logistic models were
assessed via Likelihood Ratio Tests. Given that we are
looking at a predictive model rather than a causal one,
we did not assess confounding, but instead used the
fully adjusted models as the final models. Tests of global
fit (Wald, Likelihood Ratio, and score) were significant
(p < 0.01).
Results
Characteristics of the study population
To characterize costs of pediatric diarrhea to Bolivian
families, we recruited caregivers from three geographic
areas: La Paz and El Alto, Cochabamba, and Santa Cruz
(Table 2). Children were evenly split in gender, and less
than 20% of caregivers reported rural residence. The ma-
jority of caregivers (91%) were the children’s mothers.
Most reported being SUMI-registered, and the mean age
of children was about one year. The mean family size
was just under five members, and the mean monthly in-
come was US$243, with 30% of respondents coming
from households where both spouses contributed to in-
come. However, income was not normally distributed
(median US$190). Most caregivers reported having
sought treatment at least once prior to the current visit
(significantly more common among outpatients, p < 0.01),
and the average caregiver used about one mode of
transportation to arrive (e.g. one trip in bus or one
shared taxi ride as opposed to one trip in bus and one
shared taxi ride). Approximately half the children were
outpatients, about half presented with at least one com-
plication, and 35% were experiencing their first-ever
episode of diarrhea. The mean time that the child had
been ill with diarrhea prior to the current visit was five
days. The mean time ill with diarrhea was not associated
with monthly household income (p = 0.23) or with in-
come per capita (p = 0.15) in bivariate analyses.
An analysis of demographics by inpatient status re-
vealed that inpatients and outpatients were similar on
most demographic characteristics, including child age,
child gender, rural residence, and transportations used
to arrive at the current treatments. However, inpatient
families were more likely to seek previous care, to report
SUMI, and had slightly larger households (p < 0.01).
Because of the substantial proportion of missing cost
data (50% of observations were missing some cost data),
we also analyzed demographic characteristics of those
with missing cost data. Most demographic variables
(e.g. child sex, age) were not associated with cost data
missingness. However, those with missing cost data were
significantly more likely to be inpatients (87.5% vs.
39.5%, p < 0.01), less likely to have SUMI (60.1% vs. 88%,p < 0.01), more likely to have sought previous treatment
(89% vs. 76%, p = 0.01), less likely to be dual-income
households (1% vs. 29%, p < 0.01), and less likely to have
the participating caregiver be the child’s mother (85% vs.
92%, p < 0.01). Missingness was also associated with hos-
pital (p < 0.01), but not with whether or not the hospital
was private (p = 0.94).
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To understand the economic burden that pediatric diar-
rhea places on Bolivian caregivers, we collected data re-
garding direct and indirect costs and stratified on visit
type as well as hospital type (Table 3). These analyses
revealed similar patterns. Inpatients, as compared to
outpatients, incurred significantly (p < 0.01) higher total
costs (US$45.50 vs. US$25), direct costs (US$36 vs. US
$14.50), and indirect costs (US$18.50 vs. US$13), al-
though it is worth noting that there was more missing
data for indirect costs in inpatients as compared to out-
patients. Similarly, patients attending the private hospital
as compared to those attending public hospitals also
incurred significantly (p < 0.01) higher total costs (US$59
vs. US$20), direct costs (US$43.50 vs. US$13.50), and
indirect costs (US$17.50 vs. US$12.50). The majority
of cost subcategories within direct medical costs were
also significantly higher for inpatients as compared to
outpatients and for patients at the private hospital as
compared to those at public hospitals. However, while
most non-medical direct costs were higher for inpa-
tients as compared to outpatients, non-medical direct
costs were mostly similar between patients at the
private hospital as compared to those at public
hospitals.
An analysis of the cost burden (total incurred costs as
a percentage of annual family income) showed that in-
patient families incurred significantly higher cost burdenTable 3 Mean costs ($US*) for treatment incurred by the care
551 Bolivian children seeking care for acute diarrhea, 2007 –
Type of cost Inpatients O
n Mean SEM n
Direct medical costs 297 254
Diagnostic 2.00 0.50
Medicines 5.00 1.00
Consultation Fees 2.00 0.50
Total 8.50 1.50
Direct non-medical costs 297 254
Transportation 3.00 0.50
Food during visit 2.00 0.00
Diapers 3.50 0.50
Child care 0.50 0.50
Total 9.00 0.50
Total Direct Costs 297 36.00 2.50 254
Indirect Costs (lost wages) 124 18.50 1.50 243
Total (direct and indirect) cost per episode† 254 45.50 3.00 297
Cost burden (Total Costs as % of annual income) 254 2.2 0.2 297
*Mean costs and SEMs are rounded to the nearest $0.50. †Total costs less than the
which are treated as zero in total cost calculations. **P-value for Kruskal-Wallis one-was compared to outpatient families (mean 2.2% vs.
1.4%, p < 0.01); similarly, families at the private hos-
pital incurred significantly higher cost burden as com-
pared to families attending public hospitals (mean
2.4% vs. 1.4%, p < 0.01) (Table 3). A separate analysis
just among families reporting lost wages found that
indirect costs accounted for an average 62.3% of total
incurred costs for inpatients and 40.7% of total
incurred costs for outpatients (p < 0.01), and were
equivalent to 1.1% and 0.8% of total annual income,
respectively (p = 0.90).
Given that Bolivia has subsidized healthcare for
pediatric populations, we also looked at differences in
costs and characteristics reported by SUMI as compared
to non-SUMI registered patients, though this informa-
tion was available only for 57% of the study participants.
Although hospital type (public vs. private) appeared to
be a sensitive indicator of SUMI status (>99% of SUMI-
registered patients attended a public hospital), it was not
a specific indicator (52% of non-SUMI patients attended
a private hospital). However, patterns of incurred costs
between SUMI and non-SUMI families (Table 4) were
similar to patterns by hospital type. SUMI families paid
significantly less in direct medical costs as compared to
non-SUMI-registered families (US$6 vs. US$25, p < 0.01),
though most non-medical direct costs were similar.
Indirect costs were also somewhat lower in SUMI-
registered families as compared to non-SUMI familiesgiver for an episode of pediatric diarrhea in a sample of
2009, stratified by inpatient status and hospital type
utpatients P** Private hospital Public hospital P**
Mean SEM n Mean SEM n Mean SEM
203 333
1.00 0.50 0.04 2.50 1.00 1.00 0.50 <0.01
6.50 0.50 <0.01 8.50 1.00 3.50 0.50 <0.01
19.50 2.50 <0.01 26.00 3.00 1.00 0.00 <0.01
27.00 2.50 <0.01 37.00 3.50 5.50 1.00 <0.01
203 333
3.00 0.50 0.59 2.50 0.50 3.00 0.50 0.47
1.00 0.00 <0.01 1.50 0.00 1.50 0.00 0.45
1.00 0.00 <0.01 1.00 0.00 3.00 0.50 <0.01
0.50 0.50 0.23 1.50 0.50 0.50 0.50 0.15
5.50 0.50 <0.01 6.50 1.00 8.00 0.50 0.05
14.50 1.50 <0.01 203 43.50 3.50 333 13.50 1.00 <0.01
13.00 1.50 <0.01 183 17.50 1.50 172 12.50 2.00 <0.01
25.00 2.00 <0.01 203 59.00 4.00 333 20.00 1.50 <0.01
1.4 0.2 <0.01 203 2.4 0.2 333 1.4 0.2 <0.01
sum of direct and indirect costs due to the missing values for indirect costs,
ay analysis of variance test (non-parametric). Italicized text indicates p < 0.05.
Figure 1 Histogram of cost burden incurred for a single
episode of pediatric diarrhea in a sample of 551 Bolivian
infants seeking care for acute diarrheal illness, 2007 – 2009.
Over 40% of Bolivian families in our study spent at least 1% of their
annual income on a single episode of pediatric diarrhea. The black
bars represent number of patients in each cost burden category,
with total number of patients at the top of the column. Each
column (cost burden category) represents a range of one
percentage point, for example, 0% = 0 - <1%. (N = 551).
Table 4 Mean costs ($US*) for treatment incurred by the caregiver for an episode of pediatric diarrhea in a sample of
551 Bolivian children seeking care for acute diarrhea, 2007 – 2009, stratified by SUMI status
Type of cost SUMI Non-SUMI P**
n Mean SEM n Mean SEM
Direct medical costs 266 47
Diagnostic 1.00 0.50 0.50 0.00 0.42
Medicines 4.50 0.50 5.00 1.00 <0.01
Consultation Fees 1.00 0.00 20.00 5.50 <0.01
Total 6.00 1.00 25.00 6.00 <0.01
Direct non-medical costs 266 47
Transportation 3.00 0.50 3.00 1.00 0.38
Food during visit 1.50 0.00 2.00 0.00 0.01
Diapers 2.50 0.50 4.50 1.00 0.18
Child care 0.50 0.50 0.00 0.00 0.47
Total 8.00 0.50 9.50 1.50 0.10
Total Direct Costs 14.00 1.00 34.50 6.00 <0.01
Indirect Costs (lost wages) 127 14.00 2.50 21 26.50 4.50 <0.01
Total (direct and indirect) cost per episode† 266 20.50 2.00 47 46.50 7.50 <0.01
Cost burden (Total Costs as% of annual income) 266 1.6 0.2 47 1.8 0.3 <0.01
*Mean costs and SEMs are rounded to the nearest $0.50.
†Total costs less than the sum of direct and indirect costs due to the missing values for indirect costs, which are treated as zero in total cost calculations.
**P-value for Kruskal-Wallis one-way analysis of variance test (non-parametric). Italicized text indicates p < 0.05.
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lower cost burden (1.6% vs. 1.8%, p < 0.01).
Over 40% of the study population experienced a “cata-
strophic” cost (≥1% cost burden) (Figure 1). As expected,
patients with catastrophic cost incurred higher costs as
compared to those not experiencing catastrophic cost.
The differences in contributing costs between patients
with and without catastrophic cost included indirect costs
(US$24.50 vs. US$5.50, p < 0.01), total direct costs (US$46
vs. US$7, p < 0.01), and (a component of direct costs) pre-
vious treatment costs (US$12 vs. US$2, p < 0.01).
Predictors of cost burden
To determine potential predictors of cost burden, we
constructed linear regression models with Log10 of cost
burden as the outcome (Table 5). Bivariate analysis with
the outcome, for 11 independent variables, identified
seven significant associations. SUMI status was not
assessed due to missing data. The adjusted R2 of the
fully adjusted model was 0.295, and the following vari-
ables were significant (p < 0.05): private hospital (Albina
Patiño vs. all others), whether the caregiver had sought
treatment prior to the current visit, the number of days
that the child had been ill with diarrhea prior to the
current visit, outpatient status, and the interaction term
between the number of days with diarrhea (1-unit
change) and having at least one complication (Table 5).
A sensitivity analysis using a calculation of cost burden
excluding the costs of extra food and extra diapers(given that parents may have bought these items even in
the absence of the child’s illness) found nearly identical
results. Therefore, we proceeded with the fully inclusive
cost burden when further exploring interaction. For chil-
dren presenting with at least one complication, each
additional day increased (by a decreasing amount, as
days grew) cost burden until 12 days; additional days
Table 5 Linear regression model of the relationship between risk factors and the Log10 cost burden for one pediatric
diarrheal episode, in a sample of 551 Bolivian children seeking care for acute diarrhea, 2007 - 2009












Male child 544 0.136† 0.060 0.02 0.019 0.074 0.80 0.019 0.074 0.80
Age of child (months) 518 −0.006 0.003 0.08 −0.000‡ 0.004 0.97 −0.000‡ 0.004 0.97
Number of people in household 518 −0.000§ 0.013 1.00 −0.010 0.016 0.53 −0.010 0.016 0.53
Rural residence 452 0.258† 0.088 <0.01 0.145 0.097 0.14 0.145 0.097 0.14
Hospital 530
Albina Patiño (Private) 0.471† 0.058 <0.01 0.493† 0.073 <0.01 0.494† 0.073 <0.01
All Others (Public, Reference) - - - - - - - - -
Treatment-Seeking Behavior
Sought treatment at least once previously to current
visit
462 0.764† 0.080 <0.01 0.438† 0.093 <0.01 0.438† 0.093 <0.01
Number of modes of transportation taken to current
visit
424 0.113 0.072 0.12 0.128 0.076 0.09 0.128 0.076 0.09
Number of days child had diarrhea prior to current
visit
507 0.012† 0.004 <0.01 0.024† 0.007 <0.01 0.024† 0.007 <0.01
Severity of illness
Child was an outpatient 545 −0.424† 0.057 <0.01 −0.402† 0.109 <0.01 −0.402† 0.109 <0.01
Child presented with at least one complicationδ 542 0.346† 0.058 <0.01 0.121 0.114 0.29 0.121 0.114 0.29
Child’s first episode of diarrhea 460 −0.043 0.070 0.54 0.085 0.080 0.29 0.085 0.080 0.29
Interaction term
Number of days with diarrhea (1-unit change) x at
least one complication
- - - −0.033† 0.015 0.03£ −0.034† 0.015 0.03£
*Second adjusted model excludes direct non-medical costs of diapers and extra food. †P < 0.05. ‡β = −0.0002. §β = −0.00003. δComplications defined as at least one
of the following, as diagnosed by the attending physician: electrolyte disorder, electrolyte imbalance, hypokalemia, metabolic acidosis, anemia, malnutrition, acute
respiratory infection, bronchopneumonia, intussusception, dehydration, or any other unnamed complication. £P-value associated with the overall interaction
coefficient. Italicized text indicates p < 0.05.
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http://www.biomedcentral.com/1471-2458/14/642then lowered cost burden (Figure 2). However, for chil-
dren presenting with no complications, each additional
day ill contributed to an increasingly greater cost bur-
den. Overall, we found that treatment-seeking behaviors,
hospitalization, and treatment in a private hospital were
important risk factors for increasing cost burden.
Predictors of catastrophic cost (Cost Burden Greater Than
or Equal to 1%)
To identify potential predictors of catastrophic cost, we
constructed logistic regression models (Table 6). Bivari-
ate analysis with the outcome, for 11 independent vari-
ables, identified six significant associations. SUMI status
was not assessed due to missing data. In the fully ad-
justed logistic model, we found the same significant (p <
0.05) variables as in the final linear model, with the same
directions of association as well (see above). As in the
linear model, a sensitivity analysis with cost calculations
excluding extra food and diapers also yielded very simi-
lar results, though the interaction term was non-significant, while the measure of complications was bor-
derline significant (p = 0.03) and in the opposite direc-
tion. We thus decided to proceed with the fully inclusive
cost calculations.
The odds ratio associated with the interaction term
decreased with greater differences in number of days
with diarrhea (comparing children with complications to
those without), but was not significant between differ-
ences of one to 14 days (Figure 3). The odds ratio associ-
ated with differences in number of days with diarrhea
alone increased with the number of days with diarrhea
(but became less precise), and was significant through-
out (p < 0.01). Similarly to results of the cost burden
analysis, we found that treatment-seeking behaviors,
hospitalization, and private hospital setting were import-
ant risk factors for catastrophic cost.
Discussion
The goals of this study were to quantify the financial im-
pact of a single episode of pediatric diarrhea on families
Figure 2 Interaction of number of days with diarrhea and
complications on cost burden incurred for a single episode of
diarrhea, in a sample of 551 Bolivian infants seeking care for
acute diarrheal illness, 2007–2009. For children who present with
no complications, each additional day with diarrhea prior to
treatment contributes to an increasingly greater cost burden. For
those children who present with at least one complication, each
additional day contributes to a greater cost burden until 12 days, at
which point additional days contribute to a lower cost burden. The
gray squares represent the contribution of number of days with
diarrhea to the log10 of cost burden for children presenting with no
complication. The black diamonds represent the contribution of
number of days with diarrhea to the log10 of cost burden for
children presenting with at least one complication. (N = 291).
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http://www.biomedcentral.com/1471-2458/14/642in Bolivia and to identify predictors of cost burden and
catastrophic cost, for those seeking treatment in a hos-
pital. The mean cost incurred for just one pediatric diar-
rhea episode was US$34, which could account for five to
eight days of food and fuel (for cooking and heating) for
an average Bolivian family with five members, depending
on the family’s level of food security [39]. Nearly half the
study population experienced a cost burden of over 1%,
which, for a family with the median annual income of
US$2,274, translates into US$22.74 spent on a single epi-
sode of diarrhea, or three to five days of food and fuel
for the “average” family described above. This amount is
nearly twice the average monthly expenditure on intra-
city transportation for Bolivians of “moderate” poverty
in 2000 [40]. In this study, cost burden increased, and
the risk of catastrophic cost grew, for children who were
hospitalized (versus outpatients), children whose parents
had sought prior treatment for this episode of diarrhea,
and children who had been sick for longer prior to the
current visit. Lastly, we observed that children seen in
Albina Patiño (a private hospital) showed a higher cost
burden and were more likely to report a catastrophic
cost, versus children seen elsewhere.
In our sample, indirect costs (lost wages) were a sub-
stantial burden on families. For families reporting lost
wages, indirect costs represented an average of 62% of
incurred costs for inpatients (41% for outpatients) andtranslated to 1.1% and 0.8% of annual income, respect-
ively (equivalent to 3 – 4 days of income). While two
studies of costs associated with pediatric diarrhea, in
Canada and Britain, also found indirect costs to be
important contributors to overall cost burden [18,19],
most studies from LMIC settings found indirect costs to
be minimal, if present [8-10,14]. Only one study, in
China, showed indirect costs to be an important compo-
nent of cost burden [41]. While methodology was similar
(most of the studies in LMIC settings also calculated
indirect costs based on caregiver reports), the study
populations may have been different from our Bolivian
study population [16]. In particular, we hypothesize that
our study found high indirect costs because many fam-
ilies earned income from both spouses (30%), instead of
just one. We recommend that future economic studies
and cost-effectiveness analyses of the societal costs of
pediatric diarrhea include indirect costs.
As significant predictors of cost burden and cata-
strophic cost, we identified inpatient status, previous
treatment, and number of days the child had been ill
with diarrhea prior to the current visit. A higher cost
burden for inpatients was consistent with other litera-
ture [14,15,41], and, in Bolivia, may also reflect the
higher costs associated with hospitalization versus out-
patient visits (e.g. additional medications, fees, lost
wages) [7]. In most other ways, inpatients were similar
to outpatients (although hospitalized patients were
more likely to seek previous care, to report SUMI, and
had slightly larger households). The higher cost burden
and risk of catastrophic cost associated with previous
treatment likely reflected costs associated with that
treatment, including non-medical costs as well as med-
ical costs which may or may not have been SUMI-
eligible. We believe that the measure of number of days
with diarrhea captures an element of illness severity
both independently and as modified by complications.
Children who are sick for a long time before their
parents seek hospital treatment may develop illness of a
greater severity, potentially causing higher treatment costs.
Additionally, these children may come from families that
are less equipped or inclined to seek hospital care; perhaps
parents are more fearful of incurring costs, regardless
of actual ability to pay. Data was not collected on the fear
of incurring costs, but we found no significant association
of number of days ill with diarrhea with income per capita
or monthly household income. Although rural residence
was associated with cost burden in the bivariate analysis,
consistent with some other studies [16], the association
was no longer significant once we controlled for other
variables such as hospital type and treatment-seeking be-
havior. Overall, these results point to the importance of
treatment-seeking behavior and illness severity to overall
familial cost burden.
Table 6 Logistic regression model of the relationship between risk factors and catastrophic cost (cost burden ≥ 1%) for
one pediatric diarrheal episode, in a sample of 551 Bolivian children seeking care for acute diarrhea, 2007 - 2009
Variable Unadjusted analysis Adjusted model 1 (n = 295) Adjusted model 2 (n = 295)*
N OR 95% CI P OR 95% CI P OR 95% CI P
Demographics
Male child 550 1.49† (1.06, 2.10) 0.02 1.04 (0.59, 1.86) 0.89 1.00 (0.55, 1.81) 1.00
Age of child (months) 524 0.98 (0.96, 1.00) 0.07 0.99 (0.96, 1.02) 0.53 1.00 (0.96, 1.03) 0.77
Number of people in household 524 1.02 (0.95, 1.09) 0.60 1.00 (0.88, 1.13) 0.95 0.96 (0.84, 1.09) 0.51
Rural residence 458 1.76† (1.09, 2.86) 0.02 1.54 (0.73, 3.26) 0.26 1.33 (0.62, 2.86) 0.47
Hospital 536
Albina Patiño (Private) 3.39† (2.36, 4.89) <0.01 4.13† (2.30, 7.41) <0.01 5.26† (2.86, 9.68) <0.01
All Others (Public, Reference) 1.00 - - 1.00 - - 1.00 - -
Treatment-Seeking Behavior
Sought treatment at least once previously
to current visit
467 8.05† (3.92,16.55) <0.01 3.92† (1.64, 9.35) <0.01 4.84† (1.83,12.75) <0.01
Number of transportations taken to current visit 428 1.18 (0.80, 1.75) 0.41 1.28 (0.70, 2.33) 0.42 1.79 (0.97, 3.30) 0.06
Number of days child had diarrhea prior to
current visit
513 1.02 (1.00, 1.05) 0.10 1.14† (1.05, 1.24) <0.01 1.09† (1.02, 1.16) 0.01
Severity of illness
Child was an outpatient 551 0.35† (0.25, 0.49) <0.01 0.16† (0.07, 0.37) <0.01 0.10† (0.04, 0.24) <0.01
Child presented with at least one complication‡ 548 2.10† (1.49, 2.96) <0.01 1.38 (0.57, 3.34) 0.47 0.42† (0.19, 0.93) 0.03
Child’s first episode of diarrhea 466 1.1 (0.75, 1.60) 0.64 1.47 (0.79, 2.75) 0.22 1.60 (0.83, 3.06) 0.16
Interaction term
Number of days with diarrhea (1-unit change) ×
at least one complication
- - - - 1.37† (0.59, 3.2) 0.03§ - - -
*Second adjusted model excludes direct non-medical costs of diapers and extra food. †P < 0.05. ‡Complications were defined as at least one of the following, as
diagnosed by the attending physician: electrolyte disorder, electrolyte imbalance, hypokalemia, metabolic acidosis, anemia, malnutrition, acute respiratory infection,
bronchopneumonia, intussusception, dehydration, or any other unnamed complication. §P-value associated with the overall interaction coefficient. Italicized
text indicates p < 0.05.
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http://www.biomedcentral.com/1471-2458/14/642Though few studies address the specific impact of
hospital type on familial-incurred cost, we found that
patients at the private hospital (Albina Patiño) had a
higher cost burden and were significantly more likely to
incur a catastrophic cost. This is consistent with other
research. For instance, one study of pediatric diarrhea in
Vietnam found indirect costs to be significantly higher
in a private urban clinic, versus public and rural settings
[4]; another study of illness in Indian neonates found
familial expenditure to be higher for private consulta-
tions versus public (government) physicians [42]. The
higher costs we observed in the private hospital are also
likely related to the fact that care in private facilities in
Bolivia is not covered by SUMI, Bolivia’s public insur-
ance program for children. SUMI provides free health-
care to children under five, but only after registration
(reported by 85% of our study population with this data)
and only in public facilities (attended by 62%). In our
study, families at the private hospital also had signi-
ficantly higher average costs for previous treatments,
perhaps because previous treatments also weren’t SUMI-
eligible, because they had more previous visits, or becausethey had some preference or willingness to spend more on
their child’s health. Families may elect to pay for private
consultations believing that the quality of care is better
[43], or for other unexplored reasons. While SUMI status
and hospital type were correlated, and non-SUMI families
paid significantly more in hospital fees (consult costs)
overall, non-medical direct expenditures were similar
between SUMI and non-SUMI families, and both pre-
sented to private and public hospitals. Overall, these
data indicate a need for further investigation into why
Bolivian parents take their children to private instead of
public facilities, and why SUMI-registered families still
incur direct costs even at public hospitals.
Several strengths and limitations of the study should
be noted. One strength was the representativeness of the
study results to Bolivia given the wide breadth of sites,
covering multiple regions and two types of healthcare
settings (outpatient and inpatient). A second strength
was the consistency of the significant results between
our linear and logistic models. A third strength was the
care and detail taken in the gathering of cost and income
data. Cost data was reported as that which the caregiver
Figure 3 Interaction of number of days with diarrhea and complications on risk of catastrophic cost for a single episode of diarrhea, in
a sample of 551 Bolivian infants seeking care for acute diarrheal illness, 2007–2009. The likelihood of experiencing a catastrophic cost
decreases slightly as the difference in the number of days with diarrhea increases, when comparing those with a complication to those without a
complication. When comparing children with no difference in complication status, the likelihood of catastrophic cost increases as the number of
days with diarrhea increases. The black diamonds represent the point estimate for the odds ratio comparing children with at least one complication to
those with none. The black bars are the 95% Confidence Intervals of these odds ratios. The gray squares represent the point estimate for the odds ratio
associated with differences in the number of days with diarrhea, among children with no differences in their complication status. The gray bars are the
95% Confidence Intervals of these odds ratios. The dotted gray line represents an odds ratio of 1. We present odds ratios for differences in number of
days with diarrhea from 0 to 14 days. (N = 295).
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A sensitivity analysis excluding diapers and food (which
might have been purchased anyway) from direct non-
medical costs led to similar significant model results,
with the exception that the interaction term in the
logistic model was non-significant, while the complica-
tions term was borderline significant and in the other
direction. Household income was calculated based on
direct report, and we have no reason to believe that
participants inflated or underreported their income.
One important limitation was missing information: not
all potential predictors could be assessed, with one
important covariate being SUMI status, given its high
percentage of missingness and our inability to confi-
dently impute this. Similarly, patients with missing
income data were necessarily excluded from analysis.
However, these patients were generally similar to included
patients, though they were more likely to be inpatients,
non-SUMI, and single-income households. A second
limitation was that we had only one private facility in
our sample, making it difficult to generalize conclusions
about private versus public hospitals. The study was
also limited in that it was a cross-sectional assessment
of financial burden; cost burden as measured may or
may not correlate to future financial difficulties.Conclusions
In conclusion, we have shown that hospital type, treat-
ment behavior, and appointment type were significant
predictors of overall cost burden and catastrophic cost
associated with pediatric diarrhea episodes in Bolivia.
These costs can represent five to eight days of food for
an average family, and even a cost burden of 1% can be
important in a setting where the median expenditure on
food and fuel amounts to over 60% of per capita daily
expenditure, leaving little for other purposes [39]. We
also demonstrated that indirect costs represented a
substantial burden for most families. The total incurred
costs of pediatric diarrhea, extrapolated to the national
level, may have represented approximately US$3MM
annually in societal burden during the time period prior
to full implementation of the Rotarix® vaccine into the
national immunization schedule [16]. This number is
expected to be less in the current setting, where vaccine
coverage reached ~80% as of 2011 [44].
Further research is needed in Bolivia to understand
why parents are still incurring treatment costs despite
accessing public hospitals (where care should be covered
by SUMI), and why some elect private over public facil-
ities. Future research should also assess the societal cost
burden in the post-vaccine era in Bolivia, as this
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http://www.biomedcentral.com/1471-2458/14/642estimate of familial economic impact would be a useful
way to assess the overall economic impact of the vac-
cine, particularly in a setting where health care costs
can be difficult to estimate given subsidized care pro-
grams like SUMI. Overall, our analysis highlights the
economic importance of pediatric diarrhea to Bolivian
families and suggests areas of intervention to reduce cost
burden and catastrophic cost associated with pediatric
diarrhea.
Abbreviations
LMIC: Lower Middle Income Countries.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RMB developed the study objectives, contributed data entry, completed data
cleaning and analysis, and drafted the manuscript. ERS contributed to the
design of survey instruments. ERS, MRD, and PAR participated in data entry,
preliminary data analysis, and contributed to the drafting of the manuscript.
MCC, BC, EC, RP, LT, CT, and RZ contributed to study design, oversight of
field work, and drafting of the manuscript. VI contributed to study design,
protocol, survey instruments, and contributed to the drafting of the
manuscript. JSL oversaw the development of study objectives, protocol,
survey instruments, data analysis, and manuscript drafting. The final version
of the manuscript has been read and approved by RMB, ERS, MRD, PAR, BC,
EC, RP, LT, CT, RZ, VI, and JSL. MCC passed away prior to the finalization of
the manuscript.
Acknowledgements
This work was supported in part by The Eugene J. Gangarosa Fund; the
Anne E. and William A. Foege Global Health Fund; the O.C. Hubert Charitable
Trust; the RSPH Student Initiative Fund; the NIH Global Frameworks Grant
(2007–2010); the Emory University Global Health Institute; the Laney
Graduate School at Emory University; the New Aid Fellowship; the Bolivia
National Rotavirus Surveillance Program (BNRSP); the Swedish Cooperation
ASDI-UMSA (Diarrhea Disease Project); PHS Grant UL1 TR000454 from the
Clinical and Translational Science Award Program, National Institutes of
Health, National Center for Research Resource; the Emory + Children’s
Pediatric Center Seed Grant Program; The National Institutes of Health/NIAID
grant U19-AI057266; and the National Center for Advancing Translational
Sciences of the National Institutes of Health under Award Number UL1TR000454.
RMB was supported in part by an NIH T32 training grant in reproductive,
pediatric, and perinatal epidemiology (HD052460-01). PAR was supported
by the National Institute of Allergy and Infectious Diseases (Award number
T32AI074492). JSL was supported in part by funds from the Emory University Global
Health Institute, NIH-NIAID (1K01AI087724-01) and USDA-NIFA (2010-85212-20608)
grants. The contents of this paper are solely the responsibility of the authors and
do not necessarily represent the official views of the USDA or the National
Institutes of Health. We are grateful for the support of the hospital staff and
the many study participants involved in this study.
Author details
1Department of Epidemiology, Rollins School of Public Health, Emory
University, Atlanta, GA, USA. 2Laney Graduate School, Emory University,
Atlanta, GA, USA. 3Division of Infectious Diseases, Emory University School of
Medicine, Atlanta, GA, USA. 4Hospital Mario Ortiz Suárez, Santa Cruz, Bolivia.
5Hospital Materno-Infantil, La Paz, Bolivia. 6Hospital Boliviano Holandés, El
Alto, Bolivia. 7Hospital del Niño Manuel Ascencio Villarroel, Cochabamba,
Bolivia. 8Hospital del Niño, La Paz, Bolivia. 9Centro Pediatría, Hospital Albina R.
Patiño, Cochabamba, Bolivia. 10Instituto de Biología Molecular y
Biotecnología, Universidad Mayor de San Andrés, La Paz, Bolivia. 11Hubert
Department of Global Health, Rollins School of Public Health, Emory
University, Atlanta, GA, USA. 12Department of Environmental Health, Rollins
School of Public Health, Emory University, Atlanta, GA, USA.
Received: 17 July 2013 Accepted: 27 May 2014
Published: 24 June 2014References
1. Parashar UD, Hummelman EG, Breeze JS, Miller MA, Glass RI: Global illness
and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003,
9(5):565–572.
2. Kosek M, Bern C, Guerrant RL: The global burden of diarrhoeal disease, as
estimated from studies published between 1992 and 2000. Bull World
Health Organ 2003, 81:197–204.
3. Ehrenkranz P, Lanata CF, Penny ME, Salazar-Lindo E, Glass RI: Rotavirus
diarrhea disease burden in Peru: the need for a rotavirus vaccine and its
potential cost savings. Pan Am J Public Health 2001, 10(4):240–248.
4. Fischer TK, Anh DD, Antil L, Cat NDL, Kilgore PE, Thiem VD, Rheingans R,
Tho LH, Glass RI, Bresee JS: Health care costs of diarrheal disease and
estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
J Infect Dis 2005, 192:1720–1726.
5. Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R:
Projected cost-effectiveness of rotavirus vaccination for children in Asia.
J Infect Dis 2005, 192:S133–S145.
6. Tate JE, Rheingans RD, O’Reilly CE, Obonyo B, Burton DC, Tornheim JA,
Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K,
Breiman RF, Feikin DR, Mintz ED, Widdowson MA: Rotavirus disease
burden and impact and cost-effectiveness of a rotavirus vaccination
program in Kenya. J Infect Dis 2009, 200:S76–S84.
7. Smith ER, Rowlinson EE, Iñiguez V, Etienne KA, Rivera R, Mamani N,
Rheingans R, Patzi M, Halkyer P, Leon JS: Cost-effectiveness of rotavirus
vaccination in Bolivia from the state perspective. Vaccine 2011,
29:6704–6711.
8. Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD:
Costs of diarrheal disease and the cost-effectiveness of a rotavirus
vaccination Program in Kyrgyzstan. J Infect Dis 2009,
200(Suppl 1):S195–S202.
9. Isakbaeva ET, Musabaev E, Antil L, Rheingans R, Juraev R, Glass RI, Bresee JS:
Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine.
Vaccine 2007, 25:373–380.
10. MacIntyre UE, Villiers FPRd: The economic burden of diarrheal disease in a
Tertiary Level Hospital, Gauteng, South Africa. J Infect Dis 2010,
202(Suppl 1):S116–S125.
11. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T: Economic and health
burden of rotavirus gastroenteritis for the 2003 birth cohort in eight
Latin American and Caribbean countries. Rev Panam Salud Publica 2007,
21(4):192–204.
12. Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD:
Economic costs of rotavirus gastroenteritis and cost-effectiveness of
vaccination in developing countries. J Infect Dis 2009, 200:S16–S27.
13. Centenari C, Gurgel RQ, Bohland AK, Oliveira DMP, Faragher B, Cuevasd LE:
Rotavirus vaccination in northeast Brazil: a laudable intervention, but
can it lead to cost-savings? Vaccine 2010, 28:4162–4168.
14. Mendelsohn AS, Asirvatham JR, Mwamburi DM, Sowmynarayanan TV,
Malik V, Muliyil J, Kang G: Estimates of the economic burden of
rotavirus-associated and all-cause diarrhoea in Vellore, India. Trop Med Int
Health 2008, 13(7):934–942.
15. Jin H, Wang B, Fang Z, Duan Z, Gao Q, Liu N, Zhang L, Qian Y, Gong S,
Zhu Q, Shen X, Wu Q: Hospital-based study of the economic burden
associated with rotavirus diarrhea in eastern China. Vaccine 2011,
29(44):7801–7806.
16. Burke RM, Rebolledo PA, Embrey SR, Wagner LD, Cowden CL, Kelly FM,
Smith ER, Iñiguez V, Leon JS: The burden of pediatric diarrhea: a
cross-sectional study of incurred costs and perceptions of cost among
Bolivian families. BMC Public Health 2013, 13:708.
17. World Health Organization: Guidelines for Estimating the Economic Burden of
Diarrhoeal Disease With Focus on Assessing the Costs of Rotavirus Diarrhoea.
Geneva: WHO, Department of Vaccines and Biologicals; 2005.
18. Jacobs P, Shane L, Fassbender K, Wang E, Moineddin R, Ford-Jones E:
Economic analysis of rotavirus-associated diarrhea in the metropolitan
Toronto and Peel regions of Ontario. Can J Infect Dis 2002, 13(3):167–174.
19. Lorgelly PK, Joshi D, Iturriza Gomara M, Flood C, Hughes CA, Dalrymple J,
Gray J, Mugford M: Infantile gastroenteritis in the community:
a cost-of-illness study. Epidemiol Infect 2008, 136(1):34–43.
20. Russell S: The economic burden of illness for households in developing
countries: a review of studies focusing on malaria, tuberculosis, and
human immunodeficiency virus/acquired immunodeficiency syndrome.
Am J Trop Med Hyg 2004, 71(Suppl 2):147–155.
Burke et al. BMC Public Health 2014, 14:642 Page 12 of 12
http://www.biomedcentral.com/1471-2458/14/64221. McIntyre D, Thiede M, Dahlgren G, Whitehead M: What are the economic
consequences for households of illness and of paying for health care in
low- and middle-income country contexts? Soc Sci Med 2006, 62:858–865.
22. Xu K, Aguilar A, Carrin G, Evans DB, Hanvoravongchai P, Kawabata K, Klavus J,
Knaul F, Murray CMJ, Ortiz JP, Zeramdini R, Annan S, Doorslear EV: Distribution
of health payments and catastrophic expenditures Methodology. 2005.
World Health Organization, Discussion Paper, Number 2.
23. Su TT, Kouyate B, Flessa S: Catastrophic household expenditure for health
care in a low-income society: a study from Nouna District, Burkina Faso.
Bull World Health Organ 2006, 84:21–27.
24. Ranson MK: Reduction of catastrophic health care expenditures by a
community-based health insurance scheme in Gujarat, India: current
experiences and challenges. Bull World Health Organ 2002, 80(8):613–621.
25. Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL: Household
catastrophic health expenditure: a multicountry analysis. Lancet 2003,
362(9378):111–117.
26. Li Y, Wu Q, Liu C, Kang Z, Xie X, Yin H, Jiao M, Liu G, Hao Y, Ning N:
Catastrophic health expenditure and rural household impoverishment in
china: what role does the new cooperative health insurance scheme
play? PLoS One 2014, 9(4):e93253.
27. Pradhan M, Prescott N: Social risk management options for medical care
in Indonesia. Health Econ 2002, 11(5):431–446.
28. Wagstaff A, van Doorslaer E: Catastrophe and impoverishment in paying
for health care: with applications to Vietnam 1993–1998. Health Econ
2003, 12(11):921–934.
29. Weraphong J, Pannarunothai S, Luxananun T, Junsri N, Deesawatsripetch S:
Catastrophic health expenditure in an urban city: seven years after
universal coverage policy in Thailand. Southeast Asian J Trop Med Public
Health 2013, 44(1):124–136.
30. CIA World Factbook - Bolivia: Available at: [https://www.cia.gov/library/
publications/the-world-factbook/geos/bl.html]
31. Bolivia (plurinational state of): Health Profile: http://www.who.int/gho/
countries/bol.pdf?ua=1.
32. Pooley B, Ramirez M, De Hilari C: Bolivia’s health reform: a response to
improve access to obstetric care. Stud Health Serv Organ Policy 2008,
24:199–222.
33. Widdowson M-A, Steele D, Vojdani J, Wecker J, Parashar U: Global rotavirus
surveillance: determining the need and measuring the impact of
rotavirus vaccines. J Infect Dis 2009, 200(Suppl 1):S1–S8.
34. Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, Ruiz-Matus C, Tambini G,
Andrus JK: Progress in the introduction of the rotavirus vaccine in Latin
America and the Caribbean: four years of accumulated experience.
Pediatr Infect Dis J 2011, 30(1):S61–S66.
35. Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK: Rotavirus vaccine
introduction in the Americas: progress and lessons learned. Expert Rev
Vaccines 2008, 7(3):345–353.
36. Oliveira LH, Danovaro-Holliday MC, Andrus JK, Fillipis AMB, Gentsch J,
Matus CR, RS M-AWo, Network: Sentinel hospital surveillance for rotavirus
in Latin American and Caribbean Countries. J Infect Dis 2009,
200(Suppl 1):S131–S139.
37. Zach M, Singleton J, Wall K, Delaney K: Collinearity Diagnostics Using the
Information Matrix. 2010.
38. Kleinbaum DG, Klein M, Pryor ER: Logistic Regression: A Self-Learning Text. 3rd
edition. New York: Springer; 2010.
39. Melgar-Quinonez HR, Zubieta AC, MkNelly B, Nteziyaremye A, Gerardo MF,
Dunford C: Household food insecurity and food expenditure in Bolivia,
Burkina Faso, and the Philippines. J Nutr 2006, 136(5):1431S–1437S.
40. Estadisticas Sociales: Instituto Nacional de Estadistica. 2011. http://www.ine.
gob.bo/.
41. Wang X-Y, Riewpaiboon A, Seidlein LV, Chen X-B, Kilgore PE, Ma J-C, Qi S-X,
Zhang Z-Y, Hao Z-Y, Chen J-C, Xu ZY: Potential cost-effectiveness of a
rotavirus immunization program in Rural China. Clin Infect Dis 2009,
49:1202–1210.42. Srivastava NM, Awasthi S, Agarwal GG: Care-seeking behavior and
out-of-pocket expenditure for sick newborns among urban poor in
Lucknow, northern India: a prospective follow-up study. BMC Health
Serv Res 2009, 9:61.
43. Chuma J, Gilson L, Molyneux C: Treatment-seeking behaviour, cost
burdens and coping strategies among rural and urban households in
Coastal Kenya: an equity analysis. Trop Med Int Health 2007, 12(5):673–686.
44. Pan American Health Organization: Immunization in the Americas: 2012
Summary. 2005.
doi:10.1186/1471-2458-14-642
Cite this article as: Burke et al.: The economic burden of pediatric
gastroenteritis to Bolivian families: a cross-sectional study of correlates
of catastrophic cost and overall cost burden. BMC Public Health
2014 14:642.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
